We offer end-to-end solutions for microbiome science from discovery through clinical validation. Untangle the complexity of the microbiome with CLIA-certified & ICH-GCP compliant NGS and metabolomics services and bioinformatics solutions. Results can be accessed via the CosmosID-HUB, a user-friendly and interactive software for microbiome analysis, or through customized reporting. Unravel complexities of microbial communities and decode genetic and metabolic fingerprints with advanced bioinformatic pipelines that enable clonal-level resolution, engraftment persistence analysis correlated to clinical outcomes and in silico screens that de-risk strain selection and reduce development time. Our expertise in integrative systems biology and immunology will provide the support you need to understand the microbiome in health and disease.
Sartorius BIA Separations develops and manufactures market-leading CIM® monolithic chromatographic columns for the purification and analysis of large biomolecules, such as viruses, plasmids, and mRNA, which are applied in cell and gene therapies. The company’s Cornerstone® Biomanufacturing Development Services are the result of more than 25 years of hands-on experience with the most challenging biopharmaceutical products and offer a comprehensive approach of integrated process development solutions and novel technology designed to improve the robustness and yield of large biomolecules production while improving the safety of therapeutic products. Sartorius BIA's technology for manufacturing-scale purification is already used in the production of the first commercialized advanced therapeutics; the company also has a keen presence with novel drug candidates in the clinical pipeline.
Cellexus researches, develops, and manufactures the CellMaker range of revolutionary single-use, airlift bioreactor systems to simplify, accelerate, and improve cell culture and fermentation processes with a system expertly designed for the life sciences and pharmaceutical industries.